Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending Topics
Clinical Development
Biologics
Fierce 50
Special Report
Awards Gala
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Trending T
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending Topics
Clinical Development
Biologics
Fierce 50
Special Report
Awards Gala
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
job cuts
Biotech
Cellectar lays off 60%, drops radiotherapy over new trial demand
Cellectar is halting work on its sole clinical-stage radiotherapy after receiving feedback from the FDA that a fresh study would be required.
James Waldron
Dec 11, 2024 5:40am
Kronos lays off 83% of staff, changes CEO after clinical setback
Nov 27, 2024 9:56am
Idorsia teases Tryvio licensing deal while planning 270 layoffs
Nov 27, 2024 4:15am
Cash-strapped Medigene lays off 40%, pauses plan to enter clinic
Nov 26, 2024 6:52am
CSL Behring shuts down California cell and gene therapy R&D site
Nov 18, 2024 8:35am
Gilead to lay off 72 staffers, shutter Seattle R&D office
Nov 14, 2024 1:09pm
